187 related articles for article (PubMed ID: 20724987)
21. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T
PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482
[TBL] [Abstract][Full Text] [Related]
22. Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML).
Stubbs MC; Krivtsov AV
Curr Protoc Pharmacol; 2017 Sep; 78():14.42.1-14.42.19. PubMed ID: 28892146
[TBL] [Abstract][Full Text] [Related]
23. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
[TBL] [Abstract][Full Text] [Related]
24. Defects in yolk sac hematopoiesis in Mll-null embryos.
Hess JL; Yu BD; Li B; Hanson R; Korsmeyer SJ
Blood; 1997 Sep; 90(5):1799-806. PubMed ID: 9292512
[TBL] [Abstract][Full Text] [Related]
25. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
Jamalpour M; Bergquist E; Welsh M
Exp Cell Res; 2020 Dec; 397(2):112368. PubMed ID: 33220260
[TBL] [Abstract][Full Text] [Related]
26. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
[TBL] [Abstract][Full Text] [Related]
27. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
Thiel AT; Blessington P; Zou T; Feather D; Wu X; Yan J; Zhang H; Liu Z; Ernst P; Koretzky GA; Hua X
Cancer Cell; 2010 Feb; 17(2):148-59. PubMed ID: 20159607
[TBL] [Abstract][Full Text] [Related]
28. The developmental stage of the hematopoietic niche regulates lineage in
Rowe RG; Lummertz da Rocha E; Sousa P; Missios P; Morse M; Marion W; Yermalovich A; Barragan J; Mathieu R; Jha DK; Fleming MD; North TE; Daley GQ
J Exp Med; 2019 Mar; 216(3):527-538. PubMed ID: 30728174
[TBL] [Abstract][Full Text] [Related]
29. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
[TBL] [Abstract][Full Text] [Related]
30. mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.
Robinson BW; Germano G; Song Y; Abrams J; Scott M; Guariento I; Tiso N; Argenton F; Basso G; Rhodes J; Kanki JP; Look AT; Balice-Gordon RJ; Felix CA
Br J Haematol; 2011 Feb; 152(3):307-21. PubMed ID: 21155757
[TBL] [Abstract][Full Text] [Related]
31. The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis.
Dobson CL; Warren AJ; Pannell R; Forster A; Lavenir I; Corral J; Smith AJ; Rabbitts TH
EMBO J; 1999 Jul; 18(13):3564-74. PubMed ID: 10393173
[TBL] [Abstract][Full Text] [Related]
32. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A
Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074
[TBL] [Abstract][Full Text] [Related]
33. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
[TBL] [Abstract][Full Text] [Related]
34. MLL: how complex does it get?
Popovic R; Zeleznik-Le NJ
J Cell Biochem; 2005 May; 95(2):234-42. PubMed ID: 15779005
[TBL] [Abstract][Full Text] [Related]
35. Learning from mouse models of MLL fusion gene-driven acute leukemia.
Schwaller J
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
[TBL] [Abstract][Full Text] [Related]
36. FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs.
Bueno C; Ayllón V; Montes R; Navarro-Montero O; Ramos-Mejia V; Real PJ; Romero-Moya D; Araúzo-Bravo MJ; Menendez P
Blood; 2013 May; 121(19):3867-78, S1-3. PubMed ID: 23479570
[TBL] [Abstract][Full Text] [Related]
37. Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.
Johnson JJ; Chen W; Hudson W; Yao Q; Taylor M; Rabbitts TH; Kersey JH
Blood; 2003 Apr; 101(8):3229-35. PubMed ID: 12515728
[TBL] [Abstract][Full Text] [Related]
38. Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice.
Yagi H; Deguchi K; Aono A; Tani Y; Kishimoto T; Komori T
Blood; 1998 Jul; 92(1):108-17. PubMed ID: 9639506
[TBL] [Abstract][Full Text] [Related]
39. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.
Jin S; Zhao H; Yi Y; Nakata Y; Kalota A; Gewirtz AM
J Clin Invest; 2010 Feb; 120(2):593-606. PubMed ID: 20093773
[TBL] [Abstract][Full Text] [Related]
40. Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.
Dafflon C; Craig VJ; Méreau H; Gräsel J; Schacher Engstler B; Hoffman G; Nigsch F; Gaulis S; Barys L; Ito M; Aguadé-Gorgorió J; Bornhauser B; Bourquin JP; Proske A; Stork-Fux C; Murakami M; Sellers WR; Hofmann F; Schwaller J; Tiedt R
Leukemia; 2017 Jun; 31(6):1269-1277. PubMed ID: 27840424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
